Skip to main content
. 2021 Oct 11;62(12):3005–3015. doi: 10.1111/epi.17091

FIGURE 3.

FIGURE 3

(A) Median percent reduction by focal seizure subtypes (n = 240) and (B) responder rates by focal seizure subtypes during the entire maintenance phase among all patients (maintenance population, n = 214). The median treatment duration for all patients in the maintenance population was 29.5 months